April 28, 2014

If you could reduce health costs and improve patient outcomes, would you?

That’s the question posed by the ACPHS students who produced this video advocating for the expansion of New York State’s Collaborative Drug Therapy Management (CDTM) legislation.

Most people outside of the pharmacy and health care community are not familiar with the term CDTM, but it’s a practice that can positively impact patient health.

At its most basic level, CDTM is an agreement between a prescriber and a pharmacist that provides the pharmacist with an expanded role in managing a patient’s drug therapy program. Additional pharmacist responsibilities could include performing patient assessments; ordering relevant lab tests; administering drugs; and adjusting drug regimens.

Disease states currently managed by CDTM in New York State include: Diabetes, Anticoagulation, Heart Failure, Asthma, HIV, and Oncology.

New York’s CDTM legislation was passed in 2011 but is due to sunset in September 2014 unless it is extended or expanded.

Watch the video to learn more.

Add new comment

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.